Recombinant Senataxin (SETX) (AA 900-950) antibody
Quick Overview for Recombinant Senataxin (SETX) (AA 900-950) antibody (ABIN7453328)
Target
See all Senataxin (SETX) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 900-950
-
Purpose
- Rabbit anti-Senataxin Recombinant Monoclonal Antibody [BLR050F]
-
Immunogen
- between AA 900 and 950
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IP: 6 μL/1 mg lysate
WB: 17:40:00
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- Senataxin (SETX)
-
Alternative Name
- Senataxin
-
Background
- Background: Mutations in Senataxin result in the neurodegenerative disorders Ataxia-Oculomotor Apraxia 2 (AOA2) and amyotrophic lateral sclerosis (ALS4). Senataxin bears an RNA/DNA helicase domain suggesting a role in DNA and RNA processing and has recently been found to be involved in the DNA damage response.
-
Gene ID
- 23064
-
NCBI Accession
- NP_055861
-
UniProt
- Q7Z333
Target
-